5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth
The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.
Read MoreThe findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.
Read MoreA simple, safe dietary intervention has an effect on the gut microbiome and metabolites in these patients.
Read MoreDBS results in a significant and long-lasting improvement to memory in Rett animal models strongly suggesting evaluating this approach to treat Rett patients.
Read MoreThis work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer’s disease.
Read MoreDetailed molecular characterization of endometrial carcinomas identifies potential markers for guiding more precise treatment.
Read MoreFrom the Labs joins Breast Cancer Awareness Month highlighting recent breast cancer research at Baylor College of Medicine.
Read MoreThe researchers combined computational and experimental approaches that led to the discovery of d16 and its potential anti-cancer activity.
Read MoreMicroscopic details of a newborn mouse eye showing blood vessels (pink) and macrophage immune cells (green).
Read MorePARMESAN scans public biomedical literature databases, identifies and ranks gene-gene and drug-gene regulatory relationships and even leverages curated information to predict undiscovered relationships.
Read MoreThis study reveals new insights into how the Zika virus sets up a niche in the placenta at the maternal-fetal interface.
Read More